| |
| |
|
| Insider
Information: |
Rubin Paul D |
| Relationship: |
Sr. VP Clinical Dev. &... |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
326,601 |
|
|
Indirect Shares
|
13,422 |
|
|
| Direct
Value |
$8,380,582 |
|
|
|
Indirect Value
|
$344,409 |
|
|
| Total
Shares |
340,023 |
|
|
| Total
Value |
$8,724,990 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
XOMA Corporation |
XOMA |
Sr. VP Clinical Dev. &... |
2016-03-22 |
326,601 |
2016-03-22 |
13,422 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2012-06-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,887 |
0 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-03-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,205 |
20,241 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-04-18 |
4 |
AS |
$0.00 |
$0 |
D/D |
(6,000) |
8,749 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-05-20 |
4 |
AS |
$0.00 |
$3,266 |
D/D |
(6,000) |
3,534 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,667 |
8,201 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-06-18 |
4 |
AS |
$0.00 |
$0 |
D/D |
(6,000) |
3,534 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,748 |
30,849 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
68,793 |
72,021 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-03-18 |
4 |
OE |
$0.00 |
$18,240 |
D/D |
36,347 |
96,719 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,667 |
85,386 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2014-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,748 |
98,769 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
64,900 |
142,398 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-03-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,346 |
172,744 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,666 |
124,133 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-08-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,748 |
149,093 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2016-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
198,330 |
338,654 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2016-03-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,141 |
350,795 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2016-03-22 |
4 |
S |
$0.78 |
$18,985 |
D/D |
(24,194) |
326,601 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2015-08-14 |
4 |
D |
$0.83 |
$9,003 |
D/D |
(10,801) |
138,292 |
0 |
- |
|
| XOMA |
XOMA Corporation |
VP Clinical Dev. & CMO |
• – – |
2011-12-30 |
5 |
A |
$1.09 |
$1,787 |
D/D |
1,636 |
2,658 |
0 |
- |
|
| XOMA |
XOMA Corporation |
VP Clinical Dev. & CMO |
• – – |
2011-12-30 |
5 |
A |
$1.16 |
$2,550 |
I/I |
2,208 |
2,208 |
0 |
- |
|
| XOMA |
XOMA Corporation |
VP Clinical Dev. & CMO |
• – – |
2011-09-30 |
4 |
OE |
$1.66 |
$1,699 |
D/D |
1,022 |
1,022 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2012-12-31 |
4 |
OE |
$2.28 |
$1,899 |
D/D |
833 |
2,036 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-05-20 |
4 |
OE |
$2.36 |
$1,853 |
D/D |
785 |
9,534 |
0 |
- |
|
| XOMA |
XOMA Corporation |
Sr. VP Clinical Dev. & CMO |
• – – |
2013-06-18 |
4 |
OE |
$2.36 |
$7,387 |
D/D |
3,130 |
9,534 |
0 |
- |
|
84 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
